The Ambassador of France to the United States, Mr. Gérard Araud, was in Boston on June 4th and 5th for the 25th edition of the BIO International Convention. The biggest convention dedicated to biotechnology and promoting the most recent R&D advances to the pharmaceutical industry, BIO welcomed this year around 17,000 people – the most popular edition in 10 years. Ambassador Araud inaugurated the French Pavilion at BIO, organized by Business France. He met several of the 140 French companies present at the convention and numerous spokesperson of the competitive cluster in France: Lyon Biopole, CCI-Grand-Est-Alsace Biovalley, Eurobiomed (PACA & Occitanie), Genopole (Essonne), Atlanpole (Nantes).
The Ambassador spoke during the panel “Can Boston DNA be replicated globally” organized by BIO. He mentioned the assets that France possesses regarding this matter, some of the specifics of our territory and highlighted that affordable healthcare is a right in France.
Ambassador Araud also launched the “French Tech Boston” initiative at the Sanofi-Genzyme headquarters. With a network of around sixty French entrepreneurs in Boston, the will to add Boston to the list of “French Tech” cities (alongside New York, Los Angeles and San Francisco) as proof of the dynamism of the French ecosystem in New-England.
This visit was the occasion to exchange with Bill Sibold, Executive Vice President and Director of Sanofi-Genzyme, the largest employer in bio-pharma in Massachusetts (5,000 employees). The Ambassador also met with representatives of Mérieux Développement, Ipsen and Servier – who entered the American market in 2018 with the takeover of the oncology activities of Irish giant Shire.